Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Schizophrenia Spectrum & Other Psychotic Disorders”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00484302
What this trial is testing

Specialized Addiction Treatment Versus Treatment as Usual for Young Patients With Cannabis Abuse and Psychosis

Who this might be right for
Marijuana AbusePsychotic DisordersSchizophrenia
Bispebjerg Hospital 103
Testing effectiveness (Phase 2)Study completedNCT05064319
What this trial is testing

Gabapentin for Restoring GABA/Glutamate Homeostasis in Co-occurring Bipolar and Cannabis Use Disorders

Who this might be right for
Bipolar DisorderCannabis UseSchizoaffective Disorder, Bipolar Type+5 more
Medical University of South Carolina 51
Not applicableStudy completedNCT00137267
What this trial is testing

A Brief Community Linkage Intervention for Dually Diagnosed Individuals

Who this might be right for
SchizophreniaPsychotic DisordersSubstance-Related Disorders+1 more
US Department of Veterans Affairs 102
Large-scale testing (Phase 3)Study completedNCT00960375
What this trial is testing

Smoking Cessation for Veterans With Severe and Persistent Mental Illness

Who this might be right for
Schizoaffective DisorderSchizophreniaAffective Psychosis, Bipolar+1 more
US Department of Veterans Affairs 179
Large-scale testing (Phase 3)Study completedNCT01617200
What this trial is testing

Long-Term Safety Extension Trial of Asenapine in Schizophrenia Participants Who Completed Protocol P05688 (P05689)

Who this might be right for
Schizophrenia
Forest Laboratories 105
Not applicableStudy completedNCT02974400
What this trial is testing

Evaluation of Internet-based Cognitive Behavioral Self-help Treatments for People With Psychosis

Who this might be right for
SchizophreniaHallucinationsPersecutory Delusion
University of Bern 101
Not applicableUnknownNCT04276012
What this trial is testing

Effectiveness of a Cardiovascular Risk Intervention Program in Patients With Schizophrenia (PRISCA)

Who this might be right for
SchizophreniaCardiovascular Risk Factor
Dr. Pere Roura-Poch 130
Not applicableEnded earlyNCT02717130
What this trial is testing

Aripiprazole, Abilify Maintena Collaborative Clinical Protocol

Who this might be right for
Schizophrenia
Florida Atlantic University 9
Not applicableStudy completedNCT01594528
What this trial is testing

Behavior During Experimentally Induced Pain

Who this might be right for
SchizophreniaMajor Depression
Centre Hospitalier Esquirol 49
Not applicableStudy completedNCT02360267
What this trial is testing

Pediatric Bipolar Registry

Who this might be right for
Bipolar DisorderDepressionMania+1 more
The University of Texas Health Science Center, Houston 334
Early research (Phase 1)Study completedNCT02415764
What this trial is testing

OnTrack>An Online Role-Playing Game: A Small Business Innovation Research (SBIR) Grant

Who this might be right for
PsychosisSchizoaffective DisorderSchizophrenia
Center for Social Innovation, Massachusetts 19
Not applicableNot Yet RecruitingNCT07802132
What this trial is testing

A Prospective, Observational, Single-Arm, Multicenter Real-World Study Evaluating the Treatment Pattern, Safety and Effectiveness of Xanomeline and Trospium Chloride Capsules (KarXT) in the Treatment of Chinese Adult Participants With Schizophrenia

Who this might be right for
Schizophrenia Disorder
Zai Lab (Shanghai) Co., Ltd. 250
Not applicableStudy completedNCT00108199
What this trial is testing

Generalization of Training in Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
US Department of Veterans Affairs
Not applicableStudy completedNCT01092598
What this trial is testing

Factors Association With Poor Physical Function in Older Adults With Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
University of California, San Francisco 46
Post-approval studies (Phase 4)Study completedNCT00330863
What this trial is testing

Preventing Relapse in Schizophrenia: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy

Who this might be right for
SchizophreniaSchizoaffective Disorder
Northwell Health 357
Early research (Phase 1)Looking for participantsNCT07484204
What this trial is testing

Evaluate Pharmacokinetics, Safety, and Tolerability of AX251 LAI in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Anxo Pharmaceutical Co., Ltd. 48
Not applicableStudy completedNCT02235012
What this trial is testing

Cognitive Biases Under Ketamine

Who this might be right for
Healthy Subjects
Centre Hospitalier St Anne 84
Not applicableStudy completedNCT00584519
What this trial is testing

Control of Metabolic and Cardiovascular Risk in Patients With Schizophrenia and Overweight

Who this might be right for
Schizophrenia
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 430
Not applicableStudy completedNCT02775864
What this trial is testing

Comparative Effectiveness of Adaptive Treatment Strategies for Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
New York State Psychiatric Institute 81,921
Post-approval studies (Phase 4)Study completedNCT00216632
What this trial is testing

Treatment Success in Changing From Olanzapine to Long-acting Injectable Risperidone (RISPERDAL® CONSTA™)

Who this might be right for
SchizophreniaPsychotic Disorders
Janssen Pharmaceutica N.V., Belgium 99
Next Page